The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first target, it could have applications for a variety of age-related disease.
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first target, it could have applications for a variety of age-related disease.
wrd.cm
The Daily Index // Issue #003 💡 Ready to make your first Open Source contribution? Stop overthinking it. Today’s read breaks down exactly how to find projects, navigate the workflow, and get your code merged with confidence. Grab the link in the replies! 🔗
The Daily Index // Issue #002 ⚙️ Ever wonder why a clicky pen clicks? Or what's inside a Pez dispenser? Today’s site features beautiful, interactive tear-downs of everyday products you might take for granted. Click around and see how they work. Link in replies! 👇
The Daily Index // Issue #001 📐 Think you’re a pixel-perfect frontend dev? Test your spatial awareness. This site challenges you to "eyeball" UI alignments, widths, and spacing entirely by sight. Warning: it’s incredibly addictive. Link is in the replies! 👇